SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:lup.lub.lu.se:ac27f31f-9226-420e-b1a3-04c728f5bebf"
 

Sökning: id:"swepub:oai:lup.lub.lu.se:ac27f31f-9226-420e-b1a3-04c728f5bebf" > Protein Kinase Inhi...

Protein Kinase Inhibition in Late Cerebral Ischemia after Subarachnoid Hemorrhage

Ansar, Saema (författare)
Lund University,Lunds universitet,Medicin, Lund,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medicine, Lund,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine
 (creator_code:org_t)
ISBN 9789185559206
2007
Engelska.
  • Doktorsavhandling (övrigt vetenskapligt/konstnärligt)
Abstract Ämnesord
Stäng  
  • The cerebral ischemia that occur after a subarachnoid hemorrhage (SAH) often results in death or severe disability and is a significant cause of stroke. Our hypothesis is that cerebral ischemia leads to pathophysiological receptor changes on the vascular smooth muscle cells. The changes may lead to a stronger vasoconstriction than normal in response to endogenous ligands. We are focusing on the endothelin (ET), 5-hydroxytryptamine (5-HT) and angiotensin II receptor-ligand systems. Previous studies have shown an upregulation of contractile ETB, 5-HT1B and AT1 receptors in cerebral arteries following experimental induced SAH. There is data to suggest that the intracellular pathways responsible for this upregulation involve protein kinase C (PKC) and mitogen activated protein kinase (MAPK). The aim of this thesis was to determine in detail the intracellular signaling mechanisms involved in the receptor changes in SAH. The results show that SAH induce upregulation of the contractile ETB, 5-HT1B and AT1 receptors in a time-dependent manner both at functional and molecular levels. We also showed that the PKC and MAPK pathways are involved in the late cerebral ischemia after SAH. By administrating inhibitors of PKC or ERK1/2 to the SAH rats we were able to prevent the upregulation of contractile receptors, the associated reduction in the regional CBF and neurological deterioration. Similar results were seen when the ERK1/2 inhibitor was given 6 h after the induced SAH. The main findings of this thesis, suggest that kinase inhibition is a novel target for treatment of cerebrovascular disorders such as cerebral ischemia after SAH.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Annan klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Other Clinical Medicine (hsv//eng)

Nyckelord

Neurology
neuropsychology
neurophysiology
Neurologi
protein kinase
cerebral ischemia
subarachnoid hemorrage
neurofysiologi
neuropsykologi

Publikations- och innehållstyp

dok (ämneskategori)
vet (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...
Ansar, Saema
Om ämnet
MEDICIN OCH HÄLSOVETENSKAP
MEDICIN OCH HÄLS ...
och Klinisk medicin
och Annan klinisk me ...
Av lärosätet
Lunds universitet

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy